SO
SLNO

STRS Ohio’s Soleno Therapeutics SLNO Stock Holding History

STRS Ohio’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,300
Closed -$276K – 2281
2025
Q2 		$276K Buy
+3,300
New +$247K ﹤0.01% 1544
2021
Q2 		– Sell
-573
Closed -$10K – 2403
2021
Q1 		$10K Hold
573
– – ﹤0.01% 2128
2020
Q4 		$16K Hold
573
– – ﹤0.01% 2087
2020
Q3 		$21K Hold
573
– – ﹤0.01% 2085
2020
Q2 		$19K Buy
+573
New +$24.8K ﹤0.01% 2047

Other funds holding SLNO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

STRS Ohio's SLNO Position: Q3 2025 in Review

STRS Ohio sold out of Soleno Therapeutics (SLNO) in Q3 2025, closing a stake of 3,300 shares — an estimated $276K sold.

STRS Ohio first reported a position in SLNO in Q2 2020 and held it in 5 quarters. The position peaked at $276K in Q2 2025. 240 funds tracked by Wall St. Rank hold SLNO as of Q3 2025.

  • STRS Ohio reported no remaining Soleno Therapeutics position as of Q3 2025 after selling out during the quarter.
  • STRS Ohio sold 3,300 Soleno Therapeutics shares in Q3 2025, an estimated $276K.
  • STRS Ohio first reported a position in Soleno Therapeutics in Q2 2020 and held it in 5 quarters.
  • STRS Ohio's Soleno Therapeutics position peaked at $276K in Q2 2025.
  • 240 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q3 2025.

Based on STRS Ohio's 13F filing for Q3 2025, filed 30 Oct 2025.